Leukocyte redistribution and eicosanoid changes during the autoperfused working heart-lung preparation.
We studied the role of leukocyte redistribution and eicosanoid changes in the early stages of instituting 16 rabbit autoperfused working heart-lung preparations (AWHLP). Physiological changes occurring during the transition from the intact animal to the AWHLP may determine the survival and viability of the organ blocks for transplantation. White blood cell (WBC) count decreased from 5,160/microL to 1430/microL (P less than .01) at 60 min of autoperfusion. Differential WBC counts performed in ten of these AWHLP revealed a 63% decrease in lymphocyte count and an 88% decrease in the granulocyte count at 60 min. Thus, the predominant leukocyte remaining in the circulation was the lymphocyte. Blood samples were collected from the intact animal and from the AWHLP for assay of the stable metabolites of thromboxane A2 (TxA2) and prostacyclin (PGI2). Transition from the in situ heart-lung block to the in vitro AWHLP stage caused significant changes in these metabolites. The PGI2 metabolite 6-ketoprostaglandin F1a (6KPGF1a) increased from 2680 +/- 487 to 4339 +/- 478 (pg/mL), P less than .05, while the TxA2 metabolite, thromboxane B2 (TxB2) decreased from 618 +/- 105 to 289 +/- 63 (pg/mL). However, assays of 11-dehydro-TxB2 (11-DHT), a longer lived metabolite of TxA2 (n = 7) increased (668.4 +/- 84.6 to 946.4 +/- 43.7, P less than .05). The transition from the in situ heart-lung block of the intact animal to the AWHLP involves significant physiological changes. Redistribution of leukocytes occurs with a predominant decrease in the granulocyte count, while levels of bioactive lipid mediators show a distinct large rise in the PGI2 metabolites and a lesser increase in TxA2 metabolites.(ABSTRACT TRUNCATED AT 250 WORDS)
Genco
C M
CM
Department of Cardiothoracic Surgery, New England Medical Center, Boston, MA 02111.
Bernstein
E A
EA
Connolly
R J
RJ
Peterson
M B
MB
Zhang
X
X
Somerville
K
K
Cleveland
R J
RJ
Diehl
J T
JT
D000818:Animals; D015777:Eicosanoids / Q000096:biosynthesis*; D004906:Erythrocyte Count; D016041:Heart-Lung Transplantation / Q000473:pathology / Q000502:physiology*; D007958:Leukocyte Count; D009926:Organ Preservation; D010477:Perfusion; D010976:Platelet Count; D011817:Rabbits
D015777:Eicosanoids